The Biocomputing Revolution’s Uncomfortable Truth As Silicon Valley titans continue to chase artificial general intelligence with ever-larger, energy-hungry language models, a different kind of intelligence is quietly taking root in petri dishes around the Read More
The Paradox of “Scary Science” Funding A recent achievement from the Technical University of Denmark (DTU) didn’t just push the boundaries of drug discovery; it spotlighted a fundamental flaw in how the world funds Read More
European Biotech’s Surgical Inroad: Beyond the Polymer A French startup, Tissium, armed with €30 million in private European venture capital and another €30 million from the European Investment Bank, has not just secured FDA marketing approval; Read More